首页> Frontiers in immunology> Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer.

Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Said,Dermime

第一单位： National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.;Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.;College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.

作者： Said,Dermime ^[1] ; Maysaloun,Merhi ^[2] ; Taha,Merghoub ^[3]

作者单位： National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.;Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.;College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar. ^[1] National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.;Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar. ^[2] Ludwig Collaborative, Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.;Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.;Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.;Department of Medicine, Weill Cornell Medicine, New York, NY, United States. ^[3]

关键词 dynamic biomarkers immune checkpoint inhibitors (ICI)irAEs programmed cell death ligand 1 (PD-L1)programmed cell death protein 1 (PD1)

医学主题词动物(Animals);人类(Humans);分子靶向治疗(Molecular Targeted Therapy);肿瘤(Neoplasms);预后(Prognosis);治疗结果(Treatment Outcome)

DOI 10.3389/fimmu.2021.781872

PMID 34745152

发布时间 2022-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交